sir-msc (8/24/2017): a brief timeline of hcc tumor response criteria to tace
Published 6 years ago • 1.6K plays • Length 4:57Download video MP4
Download video MP3
Similar videos
-
57:16
sir-rfs webinar (3/10/2016): management of hepatocellular carcinoma: how i do it
-
33:28
assessing response after hepatic interventional oncology
-
57:12
sir-rfs webinar (8/27/15): current staging and treatment in hepatocellular carcinoma
-
1:04:18
sir-rfs webinar (8/21/13): triaging ir treatments of hcc
-
50:32
sir-rfs webinar (10/3/2017): introduction to y-90 therapy for hcc and crc metastasis
-
5:26
hcc whiteboard #1: the epidemiology of hepatocellular carcinoma and current standard of care
-
55:31
origins of tace w/ dr. michael soulen & dr. nicholas fidelman | backtable podcast ep. 256
-
17:55
hepatocellular carcinoma: medical treatment
-
9:01
treating rare and complex cancers part 3
-
2:21
augmenting hepatocellular carcinoma response to transarterial radioembolization (vascular)
-
0:47
what is a tace procedure?
-
14:21
interactive session on hepatocellular cancer guidelines - new agents on the horizon in hcc
-
28:11
hepatocellular carcinoma - molecular approaches to treatment
-
12:01
embolization as an hcc treatment strategy
-
42:44
update: biomarkers and treatments for hcc - richard finn - 10:10 am
-
1:37:14
sir-rfs webinar (08/03/2017): sir rfs journal club
-
27:46
update on screening for hepatocellular carcinoma (hcc)
-
1:59:41
sir-rfs webinar (8/29/2016): 2016 msc - ir residency applications program directors' perspective